Ocular Therapeutix, Inc. (OCUL)
NASDAQ: OCUL · Real-Time Price · USD
7.34
+0.09 (1.24%)
At close: Oct 6, 2026, 4:00 PM EDT
7.48
+0.14 (1.87%)
After-hours: Oct 6, 2026, 7:36 PM EDT
Ocular Therapeutix Market Cap
Ocular Therapeutix has a market cap or net worth of $1.61 billion as of October 6, 2026. Its market cap has decreased by -18.80% in one year.
Market Cap
1.61B
Enterprise Value
1.09B
1-Year Change
-18.80%
Ranking
Category
Stock Price
$7.34
ChartMarket Cap Chart
Since July 25, 2014, Ocular Therapeutix's market cap has increased from $270.50M to $1.61B, an increase of 495.93%. That is a compound annual growth rate of 15.74%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2026 | 1.61B | -37.67% |
| Dec 31, 2025 | 2.59B | 92.64% |
| Dec 31, 2024 | 1.34B | 279.05% |
| Dec 29, 2023 | 354.20M | 63.68% |
| Dec 30, 2022 | 216.40M | -59.48% |
| Dec 31, 2021 | 534.00M | -63.87% |
| Dec 31, 2020 | 1.48B | 678.20% |
| Dec 31, 2019 | 189.90M | 16.08% |
| Dec 31, 2018 | 163.60M | 24.89% |
| Dec 29, 2017 | 131.00M | -37.08% |
| Dec 30, 2016 | 208.20M | -10.18% |
| Dec 31, 2015 | 231.80M | -53.78% |
| Dec 31, 2014 | 501.50M | 85.40% |
| Jul 25, 2014 | 270.50M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Nuvation Bio | 1.74B |
| Stoke Therapeutics | 1.63B |
| Syndax Pharmaceuticals | 1.59B |
| uniQure | 1.58B |
| Rapport Therapeutics | 1.54B |
| Immunocore Holdings | 1.52B |
| GH Research | 1.52B |
| Innoviva | 1.49B |